Tesaro Announces Participation in Three Investor Conferences
22 November 2016 - 8:05AM
TESARO, Inc. (NASDAQ:TSRO), an oncology-focused biopharmaceutical
company, today announced its participation in three upcoming
investor conferences. The three conferences are:
- The Leerink POLARxPRESS Bus Tour at the Convene
Conference Center in New York, New York on Wednesday, November
30. Tim Pearson, EVP and CFO of TESARO, will present on
November 30 at 9:45 AM ET.
- The Citi 2016 Global Healthcare Conference at the Lotte
New York Palace in New York, New York on Wednesday, December
7. Lonnie Moulder, CEO of TESARO, Mary Lynne Hedley,
Ph.D., President and COO of TESARO, and Tim Pearson, EVP and CFO of
TESARO, will participate in an analyst-led moderated Q&A from
3:40 to 4:20 PM ET and in meetings with investors.
- The Guggenheim Securities 4th Annual Boston Healthcare
Conference at the Intercontinental in Boston, Massachusetts on
Tuesday, December 13. Tim Pearson, EVP and CFO of TESARO,
will participate in meetings with investors.
A live webcast of the presentation at the Citi
conference will be available by visiting the Investors section of
the TESARO website at www.tesarobio.com. An archived replay of this
webcast will be available on the Company’s website for 14 days
following the conference.
About TESAROTESARO is an
oncology-focused biopharmaceutical company devoted to providing
transformative therapies to people bravely facing cancer. For more
information, visit www.tesarobio.com, and follow us on Twitter and
LinkedIn.
For additional information, please contact:
Jennifer Davis
1.781.325.1116
jdavis@tesarobio.com
Tesaro, Inc. (NASDAQ:TSRO)
Historical Stock Chart
From Mar 2024 to Apr 2024
Tesaro, Inc. (NASDAQ:TSRO)
Historical Stock Chart
From Apr 2023 to Apr 2024
Real-Time news about Tesaro, Inc. (NASDAQ): 0 recent articles
More News Articles